Immunohistochemical staining of the Excision Repair Cross-Complementing 1 (ERCC1) protein as predictor for benefit of adjuvant chemotherapy (CT) in the International Lung Cancer Trial (IALT).
- J Soria (Author)
- V Haddad (Author)
- KA Olaussen (Author)
- P Fouret (Author)
- A Dunant (Author)
- M Filipits (Author)
- Popper, H. (Author)
- F Andre (Author)
- T Le Chevalier (Author)
- E Brambilla (Author)
Activity: Talk, presentation or poster › Scientific talk or presentation › On site